ASTEX PHARMACEUTICALS, INC Patent Applications Pending
5 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-03-29: Application 18697416; Invention COMBINATORY THERAPY FOR CANCER USING BIPHENYL COMPOUND AND IMMUNE CHECKPOINT MOLECULE REGULATOR; Applicant Astex Pharmaceuticals, Inc.; Status Non Final Action Mailed.
- 2023-03-10: Application 18044978; Invention METHODS OF TREATING RIBONUCLEOTIDE REDUCTASE-RELATED DISEASES WITH A RIBONUCLEOTIDE REDUCTASE INHIBITOR; Applicant Astex Pharmaceuticals, Inc.; Status Final Rejection Mailed.
- 2022-10-25: Application PCTUS2022047766; Invention PROCESS FOR PREPARING BENZOATE SALT OF A TERPHENYL COMPOUND; Applicant ASTEX PHARMACEUTICALS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2022-02-22: Application 63312714; Invention FORMULATION OF ANTICANCER COMPOUND; Applicant Astex Pharmaceuticals, Inc.; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2024-03-29 | 18697416 | COMBINATORY THERAPY FOR CANCER USING BIPHENYL COMPOUND AND IMMUNE CHECKPOINT MOLECULE REGULATOR | Astex Pharmaceuticals, Inc. Taiho Pharmaceutical Co. Ltd. | Non Final Action Mailed | US20250049757A1 | Akiko Osada Toshihiro Shibutani | Japan Japan | ARCORIA, PAUL JOSEPH |
| 2023-03-10 | 18044978 | METHODS OF TREATING RIBONUCLEOTIDE REDUCTASE-RELATED DISEASES WITH A RIBONUCLEOTIDE REDUCTASE INHIBITOR | Astex Pharmaceuticals, Inc. Taiho Pharmaceutical Co., Ltd. | Final Rejection Mailed | US20230338342A1 | Hiroyuki Ueno Takuya HOSHINO Harold KEER Aram OGANESIAN | Japan Japan United States United States | RODRIGUEZ, RAYNA B |
| 2022-10-25 | PCTUS2022047766 | PROCESS FOR PREPARING BENZOATE SALT OF A TERPHENYL COMPOUND | ASTEX PHARMACEUTICALS, INC. TAIHO PHARMACEUTICAL CO., LTD. | RO PROCESSING COMPLETED-PLACED IN STORAGE | NIPUN DAVAR MATTHEW JOHNSON SURESH MANTHATI | United States United States United States | ||
| 2022-02-22 | 63312714 | FORMULATION OF ANTICANCER COMPOUND | Astex Pharmaceuticals, Inc. | Provisional Application Expired | Nipun Davar Jim Kou Rachna Jain | United States United States United States | ||
| 2022-02-22 | 63312712 | COMBINATION FORMULATION OF CEDAZURIDINE | Astex Pharmaceuticals, Inc. | Provisional Application Expired | Nipun Davar Jim Kou Rachna Jain | United States United States United States |